PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Obesity treatments being restricted by cash poor local services

Obesity services not deemed a priority, and patients are often victims of prejudice, say experts

2024-09-11
(Press-News.org) Obesity treatments are being restricted by cash poor local services across England with many patients being denied specialist drugs, surgery and support, an investigation by The BMJ has found.

Patients in nearly half the country can’t get appointments with specialist teams for weight loss support and care, including treatment with drugs such as semaglutide. And in nearly one in five local health areas, patients don’t have access to a bariatric surgery service, reports Elisabeth Mahase.

The government estimates that obesity costs the NHS in England around £6.5bn a year and is the second biggest preventable cause of cancer, after smoking.

Yet obesity specialists told The BMJ that services for weight management in England are not given the priority they deserve, often being the first to be cut when budgets are tight. Patients are also often the victims of prejudice among many people, including some health professionals and commissioners, who believe they are less worthy of care than other patients.

The BMJ analysed responses from all 42 of England’s Integrated Care Boards (ICBs) - responsible for planning health services for their local population - about the weight loss services they commission.

These showed that just over half of the ICBs (24 of the 42) commission both tier 3 and 4 adult weight loss services that cover their entire population and are accepting new referrals.

Just over a third of ICBs (15) reported problems with tier 3 services such as that they were currently closed to new patients (six ICBs), that they only covered part of the ICB’s catchment area (seven), or that the ICB didn’t commission any services at this level (four).

Access to tier 4 services, which provide bariatric surgery, is also restricted in many parts of the country, with seven ICBs not providing a bariatric surgery service to patients in their area.

Nicola Heslehurst, senior lecturer in maternal nutrition at Newcastle University and chair of the UK Association for the Study of Obesity, told The BMJ that the current provision of weight management services “doesn't in any way meet the need” and warned that without “radical” action to improve access to services and address all the drivers of obesity, prevalence, costs, and health inequalities would continue to rise.

England’s poor provision of weight management services is also reflected in the low number of bariatric surgeries carried out each year (around 5,000 NHS surgeries compared with 50,000 in France).

Yet consultant bariatric surgeon Ahmed Ahmed, points out that gastric bypass “is the most clinically effective and the most cost effective” treatment.

This is backed up by a cost per quality adjusted life year or QALY (a measure of years lived in good health) gain of between £2000-£4000, which is well under the NICE cut-off for good value interventions of £20,000 per QALY gained.  

When asked about the poor provision of weight management services, a spokesperson for NHS England said the NHS is “working with the Department of Health to support improvements in the obesity pathway."

[Ends] 

END


ELSE PRESS RELEASES FROM THIS DATE:

Laughter may be as effective as drops for dry eyes

2024-09-11
Laughter may be as effective as eye drops in improving symptoms of dry eye disease, finds a clinical trial from China published by The BMJ today The researchers suggest that laughter exercise could be an initial treatment for relieving symptoms of dry eye disease. Dry eye disease (DED) is a chronic condition estimated to affect around 360 million individuals worldwide. Common symptoms include uncomfortable, red, scratchy or irritated eyes. Evidence suggests that laughter therapy alleviates depression, anxiety, stress, and chronic pain, while strengthening immune ...

Path to prosperity for planet and people if Earth’s critical resources are better shared: report

2024-09-11
Earth will only remain able to provide even a basic standard of living for everyone in the future if economic systems and technologies are dramatically transformed and critical resources are more fairly used, managed and shared, according to an international research team including scientists from The Australian National University (ANU). The report, published in The Lancet Planetary Health, outlines how cities and businesses have the power to play a crucial role and become the “stewards” of critical Earth ...

Long-course radiotherapy is better than short-course for organ preservation in rectal cancer

Long-course radiotherapy is better than short-course for organ preservation in rectal cancer
2024-09-11
The COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given before surgery may be a better treatment for avoiding surgery, preserving the rectum and anus, and preventing regrowth of the primary tumour than a short course of radiotherapy for patients with rectal cancer – a type of bowel cancer. However, the overall survival and survival free of recurrence of the disease remained the same for both treatments.   These findings are from a new study published in ...

Large-scale population analysis confirms reassuring safety profile of tirzepatide

2024-09-11
As more people with type 2 diabetes (T2D) are taking medications to help manage blood sugar levels and weight loss, concerns about whether these drugs are safe have emerged. Now real-world evidence from the FDA Adverse Event Reporting System (FAERS) database reveals a reassuring safety profile for tirzepatide (TZP). The findings to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept), and published in the The Journal of Endocrinological Investigation (link below) reveal that, compared to the widely used class of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), TZP has similar gastrointestinal ...

Tirzepatide associated with greater weight loss in women than men

2024-09-11
All doses of tirzepatide, a medication approved in the EU to treat type 2 diabetes and obesity, consistently reduced body weight in women and men, but women experienced greater weight loss, according to new post hoc research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept). The post hoc analysis, which included the four SURMOUNT trials [1], compared tirzepatide with a placebo for up to 72 to 88 weeks in 4,677 adults (2,999 females, 1,678 males) living with obesity, highlighting potential sex differences in the response. Tirzepatide, a once-weekly glucose-dependent ...

Rapid control of blood sugar levels in women with gestational diabetes can reverse the risk of their children developing obesity, US study finds

2024-09-11
Swiftly achieving glycaemic control after a diagnosis of gestational diabetes can bring the baby’s risk obesity in childhood down to a level similar to that of children whose mothers did not have gestational diabetes, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September), has found. Gestational diabetes, a type of diabetes that can develop during pregnancy, affects 14% of pregnant women globally and is becoming more common, with those who are living with obesity, have a family ...

Semaglutide’s cardiovascular benefits are maintained in people with impaired kidney function

2024-09-11
The anti-obesity medication semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with overweight or obesity who don’t have diabetes, whether or not they also have impaired kidney function, according to new research to be presented at this year’s Annual Meeting of The European Association for the Study of Diabetes (EASD), Madrid (9-13 Sept). The results are based on a pre-specified analysis of the SELECT trial which found that adults with overweight or obesity but not diabetes taking semaglutide for more than 3 years had a 20% lower risk of MACE or ...

Study reveals key predictors for achieving and sustaining blood glucose control and weight loss with tirzepatide in adults with type 2 diabetes

2024-09-11
The phase 3 SURPASS-4 trial published in 2021 established that tirzepatide lowers blood sugar and supports weight loss better than insulin glargine (a long-acting insulin) for type 2 diabetes (T2D) [1]. Now new research examining a broad range of potential predictors of sustaining blood sugar control and weight loss indicates that greater weight loss, better β-cell function, and a greater decrease in low-density lipoprotein cholesterol (LDL-C or “bad cholesterol”) during the first year of tirzepatide therapy are the most ...

Avian flu found in wastewater of 10 Texas cities through virome sequencing by researchers at UTHealth Houston and Baylor College of Medicine

Avian flu found in wastewater of 10 Texas cities through virome sequencing by researchers at UTHealth Houston and Baylor College of Medicine
2024-09-11
Avian influenza A(H5N1) virus, which spread to cattle and infected 14 people this year, was detected using virome sequencing in the wastewater of 10 Texas cities by researchers at UTHealth Houston and Baylor College of Medicine. The virome is the collection of viruses in a sample, in this case a wastewater sample. The information was published in the New England Journal of Medicine. Until March 2024, H5N1 had not been detected in 1,337 wastewater samples analyzed by the team. But from March 4 to July 15 (the end of data collection for this article), H5N1 was ...

Culturing muscle cells

Culturing muscle cells
2024-09-11
Harvard stem cell biologists have pioneered a groundbreaking 3D organoid culture method for generating large numbers of adult skeletal muscle satellite cells, also known as muscle stem cells, in vitro. The ability to efficiently make functional muscle stem cells in this way is expected to accelerate understanding of and treatments for disorders of skeletal muscle, including those that are neuromuscular in origin. The new technique, detailed in Nature Biotechnology, also provides a powerful tool for studying muscle biology. "People will be able to do all these engraftment and regeneration experiments because suddenly, you have millions of cells,” said co-author and Harvard research ...

LAST 30 PRESS RELEASES:

‘Good complexity’ can make hospital networks more cybersecure

Up to one-third of antibody drugs are nonspecific, study shows

Shrinking the pint can reduce beer sales by almost 10%

Unhealthy behaviors contribute to more coronary artery disease deaths in the poor

Two common surgeries equally effective for treating blinding condition of the eyelid

NIH grant supports research into environmental factors regarding male fertility

Children’s National Hospital selected to lead next-generation BARDA Accelerator Network Special Populations Hub

What happens to patients when their GP retires or relocates?

Cancer cells may be using lipids to hide from the immune system

NASA completes spacecraft to transport, support Roman Space Telescope

University of Health Sciences earns $5.3 million from NIH to boost cancer research, support emerging scientists

Central America could play troubling new role in cocaine trade

SwRI and UTSA will create synthetic process for antibiotic drug discovery

Norwegian Afghanistan veterans more prone to anger

Black hole pairs may unveil new particles

Amsterdam UMC led research sets a step forward in the battle against MRSA

Childhood trauma linked to major biological and health risks

Beneath the brushstrokes, van Gogh’s sky is alive with real-world physics

Excess body weight and the risk of second primary cancers among cancer survivors

Outcomes by race and ethnicity following a Medicare bundled payment program for joint replacement

LJI discovery paves the way for antivirals against Ebola virus and its deadly relatives

Advanced 3D mammography detects more breast cancers, fewer false positives

How an MBA can empower entrepreneurs

Ten-year study shows tomosynthesis improves breast cancer detection

How can climate adaptation succeed in the long run?

Moderate coffee and caffeine consumption is associated with lower risk of developing multiple cardiometabolic diseases, new study finds

New four-year, $3.26 million grant from the National Institute of Neurological Disorders and Stroke establishes the Mount Sinai Center for Undiagnosed Diseases

Lupus Research Alliance announces recipients of 2024 Diversity in Lupus Research Awards

New survey from Abbott finds epidemiologists believe viral and mosquito-borne pathogens are priority concerns for disease outbreaks

A wobble from Mars could be sign of dark matter, MIT study finds

[Press-News.org] Obesity treatments being restricted by cash poor local services
Obesity services not deemed a priority, and patients are often victims of prejudice, say experts